Valcon Medical A/S - CVR: 40086714

2022, DKK

03.07.2023

Bruttoresultat

-15.350'

Primær drift

Na.

Årets resultat

-17.079'

Aktiver

67.255'

Kortfristede aktiver

22.674'

Egenkapital

56.675'

Afkastningsgrad

0 %

Soliditetsgrad

84 %

Likviditetsgrad

+500%

Resultat

03.07.2023

Årsrapport	2022 03.07.2023	2021 24.06.2022	2020 29.06.2021	2018 31.08.2020
Nettoomsætning
Bruttoresultat	-15.349.994	-6.235.445	-1.132.718	-3.020.603
Resultat af primær drift	0	-12.886.700	-3.828.076	-5.530.797
Indtægter af kapitalandele (tilknyttede og associerede)	0	0	0	0
Finansielle indtægter	18.292	1.991	98.679	0
Finansieringsomkostninger	-585.872	-1.437.435	-785.847	-38.800
Andre finansielle omkostninger	0	0	0	0
Resultat før skat	0	-14.322.144	-4.515.244	-5.569.597
Resultat	-17.079.193	-10.627.248	-3.518.179	-4.344.377
Forslag til udbytte	0	0	0	0

Aktiver

03.07.2023

Årsrapport	2022 03.07.2023	2021 24.06.2022	2020 29.06.2021	2018 31.08.2020
Kortfristede varebeholdninger	6.143.613	816.317	0	0
Kortfristede tilgodehavender fra salg og tjenesteydelser	9.902.812	6.507.985	2.638.462	2.669.208
Likvider	6.627.149	11.994.152	4.405.547	6.895.182
Kortfristede aktiver	22.673.574	19.318.454	7.044.009	9.564.390
Immaterielle aktiver og goodwill	12.044.406	7.906.488	0	0
Finansielle anlægsaktiver	5.558.020	263.100	263.100	263.100
Materielle aktiver	26.978.637	29.664.579	25.232.682	5.331.601
Langfristede aktiver	44.581.063	37.834.167	25.495.782	5.594.701
Aktiver	67.254.637	57.152.621	32.539.791	15.159.091

Aktiver

03.07.2023

Passiver

03.07.2023

Årsrapport	2022 03.07.2023	2021 24.06.2022	2020 29.06.2021	2018 31.08.2020
Forslag til udbytte	0	0	0	0
Egenkapital	56.675.233	49.435.413	639.542	9.655.623
Hensatte forpligtelser	0	0	0	0
Langfristet gæld til banker	0	0	0	0
Anden langfristet gæld	0	0	25.083.806	2.700.000
Leverandører af varer og tjenesteydelser	1.366.257	1.838.590	5.214.141	2.383.897
Kortfristede forpligtelser	4.186.313	5.915.929	6.816.443	2.803.468
Gældsforpligtelser	10.579.404	7.717.208	31.900.249	5.503.468
Forpligtelser	10.579.404	7.717.208	31.900.249	5.503.468
Passiver	67.254.637	57.152.621	32.539.791	15.159.091

Passiver

03.07.2023

Nøgletal

03.07.2023

Årsrapport	2022 03.07.2023	2021 24.06.2022	2020 29.06.2021	2018 31.08.2020
Afkastningsgrad	Na.	-22,5 %	-11,8 %	-36,5 %
Dækningsgrad	Na.	Na.	Na.	Na.
Resultatgrad	Na.	Na.	Na.	Na.
Varelagerets omsætningshastighed	Na.	Na.	Na.	Na.
Egenkapitals-forretning	-30,1 %	-21,5 %	-550,1 %	-45,0 %
Payout-ratio	Na.	Na.	Na.	Na.
Gældsdæknings-nøgletal	Na.	-896,5 %	-487,1 %	-14.254,6 %
Soliditestgrad	84,3 %	86,5 %	2,0 %	63,7 %
Likviditetsgrad	541,6 %	326,5 %	103,3 %	341,2 %

Resultat

03.07.2023

Gæld

03.07.2023

Årsrapport

03.07.2023

Nyeste:01.01.2022- 31.12.2022(offentliggjort: 03.07.2023)

Information om virksomhedens regnskabsklasse:The annual report of Valcon Medical A/S for 2022 has been prepared in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class B, as well as provisions applying to reporting class C entities. The accounting policies applied are consistent with those of last year. The annual report for 2022 is presented in DKK

Oplysning om pantsætninger og sikkerhedsstillelser:All assets has been pledged with a company pledged of DKK 5,3 mill. 50% of the inventory of produced products has been pledged as security for full filment of a profit split agreement with a vendor.

Beretning

03.07.2023

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:The supervisory board and executive board have today discussed and approved the annual report of Valcon Medical A/S for the financial year 1 January - 31 December 2022.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:Business review The purpose of the company is to offer contract processing services, white label products, and supply of raw material. Valcon Medical is a European contract manufacturing organization, specialized in the manufacturing of medical cannabis extracts. We offer a complete outsourcing solution covering every phase from development of products to regulatory documentation and market introduction. Our promise is to deliver the highest quality of products while assuring consistent and scalable supply. Valcon Medical is GMP-certified by the Danish Medicines Agency. Products are manufactured under EU-GMP and tested in accordance with DAB Eingestellter Cannabisextract, and the European Pharmacopeia, Ph. Eur. The going concern of the Company is dependent on a successful short term raise of capital/loans. The management expects to close the necessary financing within the end of August 2023 in a combination of convertible loans from existing shareholders and new equity.